Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W K Alfred Yung

Showing results (1-10 of 201) with videos related to

Pageof 21
Sort By:
Neuro-Oncology|August 20, 2010
Impact Factor number reflects sustained high qualityW K Alfred Yung
Clinical Advances in Hematology & Oncology : H&O|September 16, 2005
Current therapies for glioblastomaW K Alfred Yung
Neuro-Oncology|November 5, 2008
Moving toward the next steps in angiogenesis therapy?W K Alfred Yung
Neuro-Oncology|August 20, 2011
New impact factor number reflects sustained and enhanced growthW K Alfred Yung
Neuro-Oncology|April 27, 2013
From GWAS risk foci to glioma molecular subclassW K Alfred Yung
Neuro-Oncology|January 4, 2013
Year brings higher impact factor, more submissions for Neuro-OncologyW K Alfred Yung
Neuro-Oncology|October 15, 2014
Imaging endpoints in brain tumor clinical trials: proceedings of the January 30, 2014 Workshop. IntroductionW K Alfred Yung
Neuro-Oncology|November 1, 2013
Neuro-oncology: past milestones and the journey aheadW K Alfred Yung
Neuro-Oncology|July 31, 2010
Review of the complexities of the PI3K/mTOR pathway presages similar handling of other critical topicsW K Alfred Yung
Neuro-Oncology|August 23, 2013
Higher impact, wider influenceW K Alfred Yung
Pageof 21

Showing results (1-10 of 201) with videos related to

Sort By:
Pageof 21
Neuro-Oncology|August 20, 2010
Impact Factor number reflects sustained high qualityW K Alfred Yung
Clinical Advances in Hematology & Oncology : H&O|September 16, 2005
Current therapies for glioblastomaW K Alfred Yung
Neuro-Oncology|November 5, 2008
Moving toward the next steps in angiogenesis therapy?W K Alfred Yung
Neuro-Oncology|August 20, 2011
New impact factor number reflects sustained and enhanced growthW K Alfred Yung
Neuro-Oncology|April 27, 2013
From GWAS risk foci to glioma molecular subclassW K Alfred Yung
Neuro-Oncology|January 4, 2013
Year brings higher impact factor, more submissions for Neuro-OncologyW K Alfred Yung
Neuro-Oncology|October 15, 2014
Imaging endpoints in brain tumor clinical trials: proceedings of the January 30, 2014 Workshop. IntroductionW K Alfred Yung
Neuro-Oncology|November 1, 2013
Neuro-oncology: past milestones and the journey aheadW K Alfred Yung
Neuro-Oncology|July 31, 2010
Review of the complexities of the PI3K/mTOR pathway presages similar handling of other critical topicsW K Alfred Yung
Neuro-Oncology|August 23, 2013
Higher impact, wider influenceW K Alfred Yung
Pageof 21